The DOI matches its Crossref record.
Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price
Open accessAbstract
The U.S. pharmaceutical industry has again become the focus of considerable controversy. In understanding the economics underlying this industry, distinctions between short, medium and long-run costs are critical, as is that between economic and accounting costs. Consumers' heterogeneous valuations create strong incentives for non-uniform pricing and targeted marketing. The conflict between static efficiency (price new drugs low, near short-run marginal cost) and dynamic efficiency (price new drugs high, maintain incentives for innovation) is deep and enduring. This trade-off is becoming more severe as the relative costs of bringing new drugs to market have increased sharply.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Quesada, H. B., Baptista, A. T. A., Cusioli, L. F., Seibert, D., de Oliveira Bezerra, C., & Bergamasco, R. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.02.009 · Cited by 557
A Decade of Direct-to-Consumer Advertising of Prescription Drugs
Donohue, J. M., Cevasco, M., & Rosenthal, M. B. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa070502 · Cited by 512
The Industrial Organization of Health-Care Markets
Gaynor, M., Ho, K., & Town, R. J. (2015) · Journal of Economic Literature · doi:10.1257/jel.53.2.235 · Cited by 349
Metadata
- Authors
- Berndt, E. R.
- Venue
- Journal of Economic Perspectives
- Publisher
- American Economic Association
- Published
- 2002-11-01
- Volume
- 16
- Issue
- 4
- Pages
- 45-66
- ISSN
- 0895-3309 (ISSN-L)
- OpenAlex
- W2112345595
- Cited by
- 171
- References
- 0
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price. https://app.cochat.ai/papers/10.1257/089533002320950975
- The paper
- Berndt, E. R. (2002). Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price. Journal of Economic Perspectives. https://doi.org/10.1257/089533002320950975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.